|
RFK expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.342150E-03 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.514280E-02 |
| Normal-vs-Stage2 |
4.968200E-01 |
| Normal-vs-Stage3 |
3.54260000000606E-05 |
| Normal-vs-Stage4 |
1.87527999999659E-05 |
| Stage1-vs-Stage2 |
3.296000E-01 |
| Stage1-vs-Stage3 |
4.570500E-02 |
| Stage1-vs-Stage4 |
1.176140E-02 |
| Stage2-vs-Stage3 |
5.553500E-02 |
| Stage2-vs-Stage4 |
3.386400E-02 |
| Stage3-vs-Stage4 |
6.872200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.640000E-03 |
| Normal-vs-AfricanAmerican |
4.32930000000553E-05 |
| Normal-vs-Asian |
1.858210E-02 |
| Caucasian-vs-AfricanAmerican |
3.541900E-02 |
| Caucasian-vs-Asian |
2.367200E-01 |
| AfricanAmerican-vs-Asian |
2.175600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.613690E-02 |
| Normal-vs-Female |
5.86369999999725E-05 |
| Male-vs-Female |
3.044500E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.043900E-03 |
| Normal-vs-Age(41-60Yrs) |
1.525570E-02 |
| Normal-vs-Age(61-80Yrs) |
6.414900E-04 |
| Normal-vs-Age(81-100Yrs) |
4.536400E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.652800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.446400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.674800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.396600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.189200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.809400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
3.670300E-02 |
| Normal-vs-Grade 2 |
2.480500E-02 |
| Normal-vs-Grade 3 |
4.445300E-04 |
| Normal-vs-Grade 4 |
1.43660000007095E-07 |
| Grade 1-vs-Grade 2 |
8.154400E-01 |
| Grade 1-vs-Grade 3 |
6.494600E-01 |
| Grade 1-vs-Grade 4 |
4.402100E-02 |
| Grade 2-vs-Grade 3 |
1.663800E-01 |
| Grade 2-vs-Grade 4 |
1.182050E-04 |
| Grade 3-vs-Grade 4 |
2.237400E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
4.322300E-02 |
| Normal-vs-ccB subtype |
1.079550E-02 |
| ccA subtype-vs-ccB subtype |
3.039000E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.891940E-02 |
| Normal-vs-N1 |
1.386010E-02 |
| N0-vs-N1 |
1.133410E-01 |
|
|
